Clinical trial : hepatitis B virus genotype and a combination of end‐of‐treatment biomarkers predict severe flares after nucleos(t)ide analogue cessation
Source
Alimentary pharmacology and therapeutics - ISSN 0269-2813- (2025) p. 1-10
Opportunistic screening using point-of-care testing leads to successful linkage to care of HBV-infected migrant populations in a low endemic country
Source
Journal of virus eradication - ISSN 2055-6640-10 (2024) p. 1-6